124 related articles for article (PubMed ID: 32218830)
1. Ubiquitin-like modifier-activating enzyme 7 as a marker for the diagnosis and prognosis of breast cancer.
Lin M; Li Y; Qin S; Jiao Y; Hua F
Oncol Lett; 2020 Apr; 19(4):2773-2784. PubMed ID: 32218830
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of rabies virus replication by interferon-stimulated gene 15 and its activating enzyme UBA7.
Zhao P; Jiang T; Zhong Z; Zhao L; Yang S; Xia X
Infect Genet Evol; 2017 Dec; 56():44-53. PubMed ID: 29056542
[TBL] [Abstract][Full Text] [Related]
3. A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.
Cui Y; Jiao Y; Wang K; He M; Yang Z
Cancer Genet; 2019 Nov; 239():54-61. PubMed ID: 31561066
[TBL] [Abstract][Full Text] [Related]
4. Cryo-EM structures of Uba7 reveal the molecular basis for ISG15 activation and E1-E2 thioester transfer.
Afsar M; Liu G; Jia L; Ruben EA; Nayak D; Sayyad Z; Bury PDS; Cano KE; Nayak A; Zhao XR; Shukla A; Sung P; Wasmuth EV; Gack MU; Olsen SK
Nat Commun; 2023 Aug; 14(1):4786. PubMed ID: 37553340
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of SKA3 correlates with poor prognosis in female early breast cancer.
Zhong Y; Zhuang Z; Mo P; Lin M; Gong J; Huang J; Mo H; Lu Y; Huang M
PeerJ; 2021; 9():e12506. PubMed ID: 34993016
[TBL] [Abstract][Full Text] [Related]
6. ISG'ylation increases stability of numerous proteins including Stat1, which prevents premature termination of immune response in LPS-stimulated microglia.
Przanowski P; Loska S; Cysewski D; Dabrowski M; Kaminska B
Neurochem Int; 2018 Jan; 112():227-233. PubMed ID: 28774718
[TBL] [Abstract][Full Text] [Related]
7. Insights into the evolution of the ISG15 and UBA7 system.
Liu S; Hu G; Luo S; Wu W; Zhou Q; Jin R; Zhang Y; Ruan H; Huang H; Li H
Genomics; 2022 Mar; 114(2):110302. PubMed ID: 35134494
[TBL] [Abstract][Full Text] [Related]
8. Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.
El-Gendi SM; Mostafa MF
Pathol Oncol Res; 2016 Jul; 22(3):461-70. PubMed ID: 26597806
[TBL] [Abstract][Full Text] [Related]
9. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
Jiao Y; Fu Z; Li Y; Zhang W; Liu Y
PLoS One; 2019; 14(1):e0211291. PubMed ID: 30695070
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
Fan CN; Ma L; Liu N
J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
[TBL] [Abstract][Full Text] [Related]
11. [Predictive value of deubiquitination enzymes USP37 in the prognosis of breast cancer].
Zhang QX; Wang XC; Chen SP; Qin XT
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(12):944-8. PubMed ID: 27045719
[TBL] [Abstract][Full Text] [Related]
12. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
[TBL] [Abstract][Full Text] [Related]
14. Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon.
Xu D; Zhang T; Xiao J; Zhu K; Wei R; Wu Z; Meng H; Li Y; Yuan J
Autophagy; 2015 Apr; 11(4):617-28. PubMed ID: 25906440
[TBL] [Abstract][Full Text] [Related]
15. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
Chen H; Tian X; Luan Y; Lu H
Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
Van Asten K; Slembrouck L; Olbrecht S; Jongen L; Brouckaert O; Wildiers H; Floris G; Van Limbergen E; Weltens C; Smeets A; Paridaens R; Giobbie-Hurder A; Regan MM; Viale G; Thürlimann B; Vergote I; Christodoulou E; Van Calster B; Neven P
Oncologist; 2019 Feb; 24(2):165-171. PubMed ID: 30171067
[TBL] [Abstract][Full Text] [Related]
18. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
20. ISG15 inhibits cancer cell growth and promotes apoptosis.
Zhou MJ; Chen FZ; Chen HC; Wan XX; Zhou X; Fang Q; Zhang DZ
Int J Mol Med; 2017 Feb; 39(2):446-452. PubMed ID: 28035359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
